PTK2 and neoplasm: Similarly, treatment with a small‐molecule FAK inhibitor in KPC mice resulted in a reduction in tumor fibrosis, progression, metastasis, alongside a decrease in immunosuppressive myeloid cell populations, ultimately leading to improved survival [95].